Novavax (NVAX) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $8.79 +10.84%
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Financial Fact:
Loss from operations: -63.31M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q1 EPS of ($0.29), $0.02 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $10.39 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Estee Lauder shares jump as fiscal 2027 profit forecast tops estimates
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
